SDHB and ischemia: Itaconate demonstrates anti-inflammatory properties in vitro and in vivo by modulating SDH levels, mitochondrial respiration, and cytokine production (IL-1β, IL-18, IL-6, IL-12, NO, and HIF-1α, but not TNF-α), particularly during macrophage activation and ischemia-reperfusion injury (117).